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Abstract 
Background: Turner syndrome is a genetic disorder that affects women. It is caused by an absent or incomplete 
X chromosome, which can be presented in mosaicism or not. There are 12 cases of Turner syndrome patients who 
present structural alterations in autosomal chromosomes.
Case presentation: The present case report describes a patient with a reciprocal, maternally inherited translocation 
between chromosomes 2 and 12 with a mosaicism of X monosomy 45,X,t(2;12)(p13;q24)[95]/46,XX,t(2;12)(p13;q24)
[5]. Through genetic mapping arrays, altered genes in the patient were determined within the 23 chromosome pairs. 
These genes were associated with the patient’s clinical features using a bioinformatics tool.
Conclusion: To our knowledge, this is the first case in which a translocation (2;12) is reported in a patient with Turner 
syndrome and confirmed by conventional cytogenetics, FISH and molecular genetics. Clinical features of our patient 
are closely related with the loss of one X chromosome, however mild intellectual disability can be likely explained 
by autosomal genes. The presence of familial translocations was a common finding, thus emphasizing the need for 
familiar testing for further genetic counselling.
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Background
Turner syndrome (TS) is a chromosomal disorder caused 
by a complete or partial monosomy of the X chromo-
some. It affects about 1 out of every 2500 newborn girls. 
This is the only genetic disorders where the absence of a 
whole chromosome is compatible with life [1]. This con-
dition presents several cytogenetic variants, being the 
monosomy 45,X the most frequent (45–55%), followed 
by structural changes in a X chromosome (25–30%) as 
isochromosome of the long arm, isochromosome mosaic, 
deletions and ring chromosomes [1, 2]. In Ecuador, X 
chromosome monosomy represents 40.42%, TS mosaic 
accounts for 25.3% and structural alterations of X chro-
mosome appeared in 7.9% of TS patients [3].
TS complex phenotype is characterized by growth fail-
ure, delayed puberty, primary amenorrhea, gonadal dys-
genesis, ovarian insufficiency, alopecia, hirsutism, low 
extremity lymphedema, nail dysplasia or hypoplasia, 
vitiligo, short and webbed neck (pterygium colli), low 
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posterior hairline at the back of the neck, wide-spaced 
nipples, inverted nipples, shield shaped thorax, low set 
ears and long term complications such as kidney, car-
diovascular, and ophthalmological problems [4]. Around 
two-thirds of the girls with TS have the maternal X chro-
mosome, ruling out the possibility meiotic error in elder 
mothers [5].
For TS diagnosis, a physical assessment and cytoge-
netic testing is needed. Women with 45,X are diagnosed 
when they are born, mainly due to their dysmorphic 
characteristics and cardiovascular complications. How-
ever, in other cases the diagnosis is postponed even until 
adolescence, when the girls displayed absent of pubertal 
development, amenorrhea, and infertility [6].
Within structural chromosomal abnormalities, translo-
cations are defined as the exchange of chromosomal seg-
ments of between two non-homologous chromosomes. 
There are two types of translocations: reciprocal and 
Robertsonian [7]. The resulting chromosomal rearrange-
ments can be a balanced or unbalanced. Double strands 
breaks are prerequisites for translocations and the phe-
notype of unbalanced translocation carriers depends on 
the size, and location of the break [8].
The coexistence of autosomal translocations and struc-
tural/numerical abnormalities of the X chromosome are 
a rarely reported, there are 12 cases published [9–20]. 
Here we describe a mosaic Turner syndrome patient 
with a maternally inherited reciprocal translocation with 
breakpoints at 2p13 and 12q24.
Case presentation
Clinical report
The patient was born on July 2000 at 32 weeks of gesta-
tion after oligohydramnios diagnosis. Her measurements 
at birth were as follows: weight 2.4 kg (1.65 SDS), length 
46.5 cm (1.53 SDS) and head circumference 31.5 cm (1.75 
SDS). During the first year of life, she received endocrine 
therapy to enhance growth and ameliorate join pain. She 
was the second offspring of healthy, non-consanguineous 
parents, who had a previous miscarriage (Fig. 1). When 
she was 5  years old, an echocardiography showed she 
has mild tricuspid regurgitation and pulmonary arterial 
hypertension (41 mmHg).
Physical examination in the first medical appointment 
on June 2006 evidenced low set ears, pectus excavatum, 
ogival palate and wide-spaced nipples (Fig.  2). Based 
on the symptoms and karyotype, TS was diagnosed. 
From 7 years of age, she has been diagnosed with myo-
pia. The second medical appointment in 2012 confirmed 
the diagnosis and determined a reciprocal translocation 
using Giemsa trypsin G-banding (GTG). In 2015, she 
had thyroid disorders and was treated with levothyrox-
ine, besides her tonsils were removed. The patient did 
not have cardiovascular diseases. She had mild intel-
lectual disability. At puberty (15  years old), she showed 
primary amenorrhea, underdeveloped breasts, juvenile 
arthritis, nail dysplasia, short stature (1 m, − 9.76 SDS), 
and lymphedema of the feet, so she wore orthopedic 
insoles for walking. In the third medical examination 
the 16-year-old patient has an estimated 3-year delay in 
bone-age. The patient was on a hormone replacement 
therapy (patches) to stimulate sexual development. As 
an ultrasound scan showed no ovaries, genetic coun-
seling was recommended to overcome future infertility 
complications.
Cytogenetic and genomics assessment of proband 
and parents
In 2006, the patient was diagnosed with a monosomy X 
mosaicism 45,X[90]/46,XX[10]. In 2012, with a better 
G-banding resolution, a reciprocal translocation with 
a 45,X,t(2;12)(p13;q24)[95]/46,XX,t(2;12)(p13;q24)[5] 
karyotype was found (Fig. 3a). To determine whether the 
translocation was inherited or de novo, her parents were 
Fig. 1 Family tree of the Turner syndrome proband carrier of the 
translocation (2;12)
Fig. 2 Clinical photographs of the patient. a At 10 years old, b at 
16 years old
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karyotyped. The father had a normal karyotype, 46,XY 
(Fig. 3b), while the mother carried the reciprocal trans-
location 46,XX,t(2;12)(p13;q24) and transmitted it to her 
child (Fig. 3c).
The reciprocal chromosomal exchange between chro-
mosome 2 and 12 was visualized using fluorescence 
probes on the patient’s lymphocytes. Signals for the 2pter 
(Agilent, Santa Clara), 2p23 (ALK), and 2p21 (EML4) 
(Abbott Molecular, Abbott Park, IL) probes were in one 
normal chromosome 2 and in the derivative chromo-
some 12, der(12). One signal of the 12qter (Agilent, Santa 
Clara) was located in the telomere of chromosome 12 
and in the derivative chromosome 2, der(2) (Fig. 4).
Extracted DNA from the patient and her mother were 
hybridized in the  CytoScan® 750  K Array separately 
(Affymetrix, Santa Clara, CA, USA). The arrays were 
processed in the Fluidics Affymetrix 450 Station and 
scanned with GeneChip™ 3000 (Affymetrix, Santa Clara, 
CA, USA). The software used for the analysis was Affym-
etrix Chromosome Analysis Suite version 2.1. The quality 
control thresholds were: SNPQC ≥ 15.0; MAPD ≤ 0.25; 
Waviness SD ≤ 0.12. Smoothing setting was On and 
the Joining Option marked 25 markers, 200 kbp. The 
microarray data were interpreted according to the anno-
tations of genome version “Genome browser hg19, Feb-
ruary 2009” (GRCh37/hg19). Array results of the proband 
showed Copy Number Variations (CNV) in several auto-
somes and sex chromosomes, being the loss of the X 
chromosome the largest genomic alteration as indicated: 
arr[GRCh37] Xp22.33p11.22(168,551_53,465,323) × 1 
dn,Xp11.22(53,465,326_53,477,877) × 4 mat,Xp11.
22q28(53,477,878_155,233,098) × 1 dn. The 155.05-
Mb loss of X chromosome involved 976 genes. In the 
chromosome participating in the translocation the 
Fig. 3 Patient and parents’ karyotypes. a Patient with mosaic X chromosome monosomy and t(2;12). b Father with normal karyotype. c Mother 
carrier of the t(2;12)
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proband have the following CNVs: arr[GRCh37] 12q11
q12(38,012,530_38,385,512) × 1, 12q13.11(46,515,130_
46,538,053) × 1, 12q21.32 (88,497,575_88,499,437) × 1 
mat, 2p24.3 (16,062,908_16,095,671) × 1, 2p22.3 
(145,196,729_145,231,557) × 3. None of them in the 
breakpoints, which confirmed the presence of a balanced 
translocation (Fig. 5a). The 3.05-Mb whole genome gain 
in the proband comprised 68 genes while the 184.70-Mb 
loss represented 1018 genes. The mother showed a total 
of 4.80 Mb of CNVs, with a gain of 1.70 Mb and a loss of 
3.11 Mb (Fig. 5b).
The maternal genomic material displayed a loss at 2p21, 
involving MSH2. MSH2 exon 13 along with its intronic 
splice-site flanking regions were amplified and sequenced 
using Big Dye Terminator v3.1 (Applied Biosystems, 
Austin, TX) in the Genetic Analyzer 3500 (Applied Bio-
systems, Austin, TX). Primers and PCR amplification 
conditions were previously reported [21]. In the targeted 
region the rs2303428 polymorphism was homozygous 
(C/C) for the mother and heterozygous for the patient 
(C/T) (Fig. 6).
Although the patient displayed mostly Turner phe-
notypic traits, she has several gain and loss regions that 
harbor autosomal genes. To explore the clinical features 
associated with these genes, a functional genomic anal-
ysis was performed in ToppFun portal based on refined 
list of autosomal genes (shared genes between mother 
and proband excluded) (Additional file 1: Table S1). Dis-
eases associated with the refined gene list were retrieved 
using the following settings: false discovery rate (FDR) as 
the correction method and p value cutoff of 0.05 (Addi-
tional file 1: Table S2) [22].
Discussion and conclusion
Monosomy of X chromosome is the most common 
cause of TS (50%), followed by X chromosome mono-
somy mosaicism (15–23%) [23]. TS females are typically 
shorter and have delayed puberty, as seen in our patient. 
Cardiovascular (50%) and kidney (33%) diseases are asso-
ciated comorbidities, however our patient has overcome 
her cardiac complications and have never shown kidney 
affections [5]. Symptoms occurrence and severity vary 
Fig. 4 FISH on chromosomes 2 and 12 implicated in the balanced translocation. Location of FISH probes in normal chromosomes 2 y 12 (a) and 
derivatives chromosomes 2 and 12 (b). c 2p telomere (green). d 12q telomere (red) and 2p21 probe: EML4 gene (green). e 2p21 probe (green). f 
2p23 probe: ALK gene (green and read combination)
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according the percentage of 45,X/46,XX mosaicism. TS 
mosaic patients did not have heart surgery or take anti-
hypertensive medication [24].
Reciprocal translocations are the most common struc-
tural with an approximate incidence of 1 in 500–625 live-
births [25]. They can be originated by non-homologous 
chromosomal rearrangements, exposure to genotoxic 
agents that damage DNA or familiar inheritance. Less 
than 6% of reciprocal translocations carriers have clinical 
features, such as autism, intellectual disability or congeni-
tal abnormalities, due to micro-deletions, duplications or 
intergenic losses [26]. The mother of our proband, who 
Fig. 5 Genetic mapping array. a Patient. b Patient’s mother (blue triangle: gain; red triangle: loss)
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carried the translocation, is completely healthy and did 
not seek medical care [16]. In contrast, our patient search 
for medical assistance due to her symptoms related to TS 
and the reciprocal translocation discovery was an inci-
dental finding.
The coexistence of autosomal translocations and TS 
cases is rarely informed. From the 12 cases published 
and including the case reported in this study, Robertso-
nian translocation between chromosome 13 and 14 was 
the most frequent (38.5%), followed by t(1;2) (15.4%). 
The other autosomal translocations t(1;9), t(2;12), 
t(2;22), t(4;16), t(8;19), t(15;22) were uniquely found in 
TS patients. In the 13 cases, 9 were inherited, 3 were de 
novo and the origin of one was not detected as parental 
karyotype was not examined. Our case is the first female 
with mosaic X chromosome monosomy and a recipro-
cal translocation involving chromosome 2 and 12. The 
breakpoints were determined by conventional cytoge-
netics on 2p13 and 12q24. FISH probes confirmed that 
the translocated region in chromosome 2 comprised the 
segment from 2p21 to 2pter, while in chromosome 12 the 
terminal band 12q24 was exchanged.
Considering our patient and 8 out of 12 cases with a 
fully described phenotype, the most frequent features 
were delayed postnatal growth, low posterior hairline, 
low seat ears, dysmorphic nails, primary amenorrhea, 
ogival palate, short and webbed neck, wide-spaced nip-
ples, lymphedema of the hands and feet, normal cardio-
vascular parameters and renal function (Additional file 1: 
Table S3). The latter mentioned characteristics are typical 
sign of TS with no additional phenotypic effect associ-
ated with the translocations as individuals have balanced 
complement of genes and the translocation breakpoints 
mapped outside coding genes or regulatory regions [27]. 
Our proband displayed distinctive traits such as mild 
intellectual disability, myopia, pectus excavatum, thyroid 
problems and juvenile arthritis, so it is speculated that 
the genes responsible for this phenotype may be altered.
It has been suggested that translocations do not affect 
to the X chromosome disjunction in the gametogenesis, 
since it has been reported that the X chromosome in a 
TS patient, carrier of a maternally inherited transloca-
tion, had a material origin [17]. In other cases the recip-
rocal translocations and X chromosome aberrations are 
de novo [16, 19, 22]. Authors considered the possibility 
that translocations might influence non-disjunction dur-
ing early stages of embryonic development [15].
In reciprocal translocations a cross-shaped quadriva-
lent is formed during gametogenesis and according to 
the chromosome segregations balanced and unbalanced 
gametes are produced. The resulted gametes can be 
grouped among four segregation modes: Alternate, Adja-
cent I, Adjacent II, 3:1 and 4:0. Out of the 8 possible pairs 
of gametes, only one pair resulted from alternate segrega-
tion, one genetically normal and the other balanced, will 
produce viable offspring when fertilized [28]. The rest of 
segregation modes will lead to imbalances. Hence it is 
most likely that alternate segregation enables our patient 
birth. In our family tree, the maternal uncle’s wife had a 
miscarriage, consequently it may be speculated that he 
is a healthy carrier of the t(2;12) translocation and that 
the spontaneous abortions might be a result of his unbal-
anced gametes fertilization.
Fig. 6 Sanger sequencing of the exon 13 of MSH2 gene. a Patient. b Patient’s mother
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Our group and others have found additional chromo-
somal changes alongside with structural chromosome 
aberrations, consequently genome-wide copy analysis 
was performed [8, 29]. After comparing whole genome 
CNVs in the proband versus her mother, it was found 
a net gain of 1.36 Mb and a net loss of 181.58 Mb. The 
absence of one X chromosome contributed to a large 
base pair loss in the proband.
Combining the genetic information and the medical 
record, genotype–phenotype correlation evidenced sev-
eral genes responsible for the expression of Turner phe-
notype. For instance SHOX gene, located in the pseudo 
autosomal region of the X chromosome, is associated 
with idiopathic short stature and TS [30]. This is consist-
ent with the patient abnormalities in body height that 
required hormonal treatment from childhood.
The prevalence of ovarian failure and visual defect 
might be explained as they share a similar genetic path-
way. USP9X gene, located in X chromosome, is responsi-
ble of gonadal dysgenesis in TS cases, while in Drosophila 
it plays a role in eye and ovary development. Eye defects 
seemed not to be correlated with any TS karyotype or its 
variants [31]. Our patient has been diagnosed with myo-
pia in her childhood and during her puberty through a 
pelvic echography the absence of ovaries was confirmed. 
Other genes such as OPN1MW, PHEX, TEX28 are associ-
ated with X-linked myopia [22].
For the mapping array bioinformatics analysis, autoso-
mal genes exclusively altered in the proband were evalu-
ated. Common autosomal genes either gained or lost in 
the patient and her mother were not considered, as the 
mother was healthy and possibly her CNVs were benign. 
It has been reported that intellectual disability is a not 
a feature of TS and that only structural sex chromo-
some abnormalities can cause mental disturbances [32]. 
In this regard, our patient had a mild cognitive impair-
ment, that might be likely related to autosomal genes. In 
the functional enrichment analysis, mild cognitive dis-
orders and intellectual disability were significant terms. 
Besides, other medical complications mainly cancerous 
process were associated terms with autosomal genes in 
CNVs regions [22]. Thus, long-term health surveillance is 
highly recommended in case these malignancies have a 
late onset.
The amplification and sequencing of MSH2 gene 
revealed the patient was heterozygous for the 
rs2303428 polymorphism (T/C), whereas her mother 
was homozygous for the mutant allele (C/C). Array 
results evidenced the mother had loss the 2p21 region 
that comprised MSH2. Two possibilities arise, one is 
that lost region have the wild type allele, in which case 
the mother was heterozygous or that the lost region 
contain the mutant allele. Based on the evidence the 
proband inherited the mutant allele from her mother. 
MSH2 participates in the DNA repair system and cor-
rect wrong post-replicative base pair pairing. It forms a 
heterodimer complex with MSH6, MSH3, which binds 
to DNA mismatches and initiates DNA repair. MSH2 
mutations have been related to endometrial cancer 
and hereditary nonpolyposis colorectal cancer [32]. 
MSH2-deficiente cell lines exhibited a faulty mismatch 
recognition, microsatellite instability, increased recom-
bination between homologous (non-identical regions) 
DNA sequence, in other words a reduction of genomic 
stability. Family members with MSH2 germline muta-
tions had somatic frameshift mutations in cellular 
growth, apoptosis and DNA repair genes [33]. Elevated 
frameshift mutations were also detected in Mhs2 het-
erozygous mouse models, suggesting a haploinsuf-
ficiency of this tumor suppressor gene [34]. It can be 
hypothesized that maternal MSH2 haploinsufficiency 
promoted genomic instability which was transmitted to 
her offspring.
In a family case, mother and daughter have X chromo-
some abnormalities and a balanced translocation with a 
45,X,t(4;16)[2]/46,XX,t(4;16)[93]/47,XXX,t(4;16)[5] and 
45,X,t(4;16)[9]/46,X,i(X)(q10),t(4;16)[91] karyotypes in 
their lymphocytes, respectively [11]. This highlighted the 
relevance of parental chromosome analysis of TS patients 
with a reciprocal, not only to identify the origin of the 
but also to evaluate whether parents carry numerical X 
chromosome abnormalities in a mosaic form. Normal 
fertility in women with 45,X could be explained by the 
presence of an additional normal cell line in their gonads 
or the absence of gonadal mosaicism. Annerén et al. [18] 
reported that an elder mosaic Turner’s syndrome woman, 
with a familial reciprocal translocation detected in lym-
phocytes and fibroblast, delivered 3 normally developed 
children and had not prior history of abortion. The latter 
cases showed family planning genetic counselling should 
be performed in a case-by-case basis.
All in all, based on patient’s symptoms and the presence 
of mosaic karyotype with one cell line with X chromo-
some loss, TS was diagnosed. Additionally, a maternally 
inherited reciprocal translocation was noted between 
chromosome 2 and 12. Possibly the maternal side of the 
family carried the balanced translocation as recurrent 
miscarriages are seen in the family tree. Through genetic 
mapping arrays analysis, a genotype–phenotype correla-
tion could be performed. Patient symptoms are closely 
related to the loss of homologous sex chromosome. The 
combination of cytogenetics, and molecular biology 
techniques provided a comprehensive analysis of the 
patient genome alterations that aids genetic counseling.
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